Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. (joseph.kuti@hhchealth.org)
Am J Health-Syst Pharm - 2024 - ;51,1:

Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. (david.nicolau@hhchealth.org)
Am J Health-Syst Pharm - 2018 - , 75, 1:36-44

Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
Ghazi I.M, Hamada Y, Nicolau D.P. (dnicola@harthosp.org)
ASHP Midyear - 2015 -

Compatibility of isavunazonium sulfate during simulated Y-site administration.
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. (dnicola@harthosp.org)
ASHP Midyear - 2015 -

Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. ()
Am J Health-Syst Pharm - 2011 - ; 68: 2265-2270.

Stability of meropenem in a portable infusion device in a cold pouch.
Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R. (rquint@ harthosp.org)
Am J Health-Syst Pharm - 2000 - ; 57: 992-995.